The Anthrax Vaccine Program: an analysis of the CDC's recommendations for vaccine use.
The anthrax vaccine was never proved to be safe and effective. It is one cause of Gulf War illnesses, and recent vaccinees report symptoms resembling Gulf War illnesses. The vaccine's production has been substandard. Without adequate evaluation, the Food and Drug Administration recently approved (retrospectively) significant changes made to the vaccine's composition since 1990. The vaccine's mandatory use for inhalation anthrax is "off-label." A skewed review of the vaccine literature by the Centers for Disease Control and Prevention (CDC) led to remunerative collaborative research with the army, involving civilian volunteers. Despite acknowledging possible fetal harm, the CDC offered the vaccine to children and pregnant women. New trends could weaken prelicensure efficacy and safety review of medical products intended for biodefense and avoid manufacturer liability for their use.
Nass
Meryl
M
Parkview Hospital, Brunswick, ME, USA.
D000881:Anthrax / Q000276:immunology / Q000517:prevention & control*; D022122:Anthrax Vaccines / Q000008:administration & dosage / Q000009:adverse effects* / Q000592:standards; D001694:Biological Warfare / Q000517:prevention & control*; D002487:Centers for Disease Control and Prevention, U.S.; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004348:Drug Labeling / Q000331:legislation & jurisprudence; D006801:Humans; D017589:Immunization Programs / Q000592:standards*; D019570:Inhalation Exposure / Q000517:prevention & control; D008889:Military Personnel; D016273:Occupational Exposure / Q000517:prevention & control*; D018923:Persian Gulf Syndrome / Q000209:etiology; D011057:Politics; D018570:Risk Assessment; D012449:Safety; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D022122:Anthrax Vaccines